Evidence map›Paper›PMID 30459604›Full record

ArticleFrontiers in pharmacology2018

Cerium Oxide Nanoparticles Re-establish Cell Integrity Checkpoints and Apoptosis Competence in Irradiated HaCat Cells via Novel Redox-Independent Activity.

Fanny Caputo, Anna Giovanetti, Francesca Corsi, Vittoria Maresca, Stefania Briganti, Silvia Licoccia, Enrico Traversa, Lina Ghibelli

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Radioprotective Potency of Nanoceria.Current radiopharmaceuticals · 2024
    Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Fanny CaputoDepartment of Chemical Science and Technologies, University of Rome Tor Vergata, Rome, Italy.
Anna GiovanettiENEA SSPT-TECS-BIORISC, Rome, Italy.
Francesca CorsiDepartment of Chemical Science and Technologies, University of Rome Tor Vergata, Rome, Italy.
Vittoria MarescaSan Gallicano Dermatological Institute IRCCS, Rome, Italy.
Stefania BrigantiSan Gallicano Dermatological Institute IRCCS, Rome, Italy.
Silvia LicocciaDepartment of Chemical Science and Technologies, University of Rome Tor Vergata, Rome, Italy.
Enrico TraversaSchool of Materials and Energy, University of Electronic Science and Technology of China, Chengdu, China.
Lina GhibelliDepartment of Chemical Science and Technologies, University of Rome Tor Vergata, Rome, Italy.
University of Rome Tor Vergata · ITSan Gallicano Hospital · ITNational Agency for New Technologies, Energy and Sustainable Economic Development · ITUniversity of Electronic Science and Technology of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cerium oxide nanoparticles (CNPs) are potent radical scavengers protecting cells from oxidative insults, including ionizing radiation. Here we show that CNPs prevent X-ray-induced oxidative imbalance reducing DNA breaks on HaCat keratinocytes, nearly abating mutagenesis. At the same time, and in spite of the reduced damage, CNPs strengthen radiation-induced cell cycle arrest and apoptosis outcome, dropping colony formation; notably, CNPs do not possess any intrinsic toxicity toward non-irradiated HaCat, indicating that they act on damaged cells. Thus CNPs, while exerting their antioxidant action, also reinforce the stringency of damage-induced cell integrity checkpoints, promoting elimination of the "tolerant" cells, being in fact radio-sensitizers. These two contrasting pathways are mediated by different activities of CNPs: indeed Sm-doped CNPs, which lack the Ce

Indexed as

anticancer therapyapoptosiscerium oxide nanoparticlesDNA damage responseDNA integrity checkpointsradio-sensitization

Identifiers

PMID30459604
PMCPMC6232693
OpenAlexW2898009735

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.